Roche MRSA/SA Assay Gains 510(k) Clearance | GenomeWeb

NEW YORK (GenomeWeb) – Roche today said that the US Food and Drug Administration cleared the cobas MRSA/SA test for the early, simultaneous detection of methicillin-resistant Staphylococcus aureus and methicillin-sensitive Staphylococcus aureus directly from nasal specimens. 

The PCR-based assay detects both bacteria directly from a single specimen and is for use on the automated cobas 4800 system, Roche said, adding that the approach requires less hands-on time and helps laboratories to reduce costs and improve turnaround time. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.